New York, NY, United States of America

Decherd D Stump

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal3 out of 832,966 
Other
 patents

Years Active: 2006-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Decherd D Stump: Innovator in Hepatitis C Research

Introduction

Decherd D Stump is a notable inventor based in New York, NY (US). He has made significant contributions to the field of hepatitis C research, holding a total of 3 patents. His work focuses on novel polypeptides that have the potential to impact vaccine development and therapeutic strategies.

Latest Patents

Stump's latest patents include innovative findings related to hepatitis C virus (HCV) polypeptides. One of his patents, titled "Alternate reading frame hepatitis C virus peptides and uses thereof," presents novel HCV polypeptides that are not encoded by the standard HCV open reading frame. These polypeptides are valuable for vaccine compositions, diagnosing HCV infection, and serving as therapeutic targets. Another patent, "Hepatitis C virus peptides and uses thereof," reiterates the importance of these alternate reading frame polypeptides in similar applications.

Career Highlights

Throughout his career, Decherd D Stump has focused on advancing the understanding of hepatitis C. His research has led to the development of innovative solutions that address critical challenges in the diagnosis and treatment of HCV. His contributions have been recognized within the scientific community, underscoring his role as a key innovator in this field.

Collaborations

Stump has collaborated with notable colleagues, including Andrea Branch and Jose L Walewski. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his research.

Conclusion

Decherd D Stump's work in hepatitis C research exemplifies the importance of innovation in addressing public health challenges. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…